Bain Capital Specialty Finance Inc
NYSE:BCSF
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.93
17.29
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q3-2023 Analysis
Bain Capital Specialty Finance Inc
Bain Capital Specialty Finance reported commendable third-quarter profits in 2023, marking a period of continued financial prosperity. The company experienced a sizeable growth in net asset value, which rose from $17.44 to $17.54 per share; this increment of 60 basis points signals a company on the rise. Investors found reason to celebrate as the quarter concluded with earnings per share reaching $0.52, translating into a 12.0% annualized return on book value. Further bolstering investor morale, a solid spillover income of $0.79 per share promises enhanced dividend and net asset value (NAV) stability, showcasing robust undistributed income.
The company declared a dividend of $0.42 per share for the fourth quarter, projecting an appealing 9.6% annualized yield based on the September 30th book value. Investment funding also saw active engagement, with approximately $110 million funneled into 40 portfolio companies, featuring both new investments and expansions of existing ones. In-line with their strategic approach, over 90% of these new funding efforts concentrated on first lien senior secured loans, a niche where the company has demonstrated both preference and prowess.
Market observations reveal a modest upturn in new loan volumes in the private credit market for Q3, albeit still lower than historical levels. That said, Bain Capital Specialty Finance remains steadfast in its strategy, favoring mid-market companies and the safety net of firm lender controls. The average spread of new portfolio company investments hit approximately 650 basis points, yielding an impressive 12% return when accounting for current base rates. With a weighted average net debt-to-EBITDA leverage of 4.0x on these new loans, the company is maintaining conservative capital structures, prepared to face economic fluctuations with resilience.
Bain Capital Specialty Finance's portfolio demonstrates both diversity and health, as evidenced by its negligible nonaccrual rates at just 1% of the portfolio's fair value. The company's investment portfolio boasts a fair value of approximately $2.4 billion with investments spread over 143 companies across 30 different sectors. Notably, investments gravitate heavily towards first lien senior secured loans, comprising 64% of the total portfolio—a strategy reflecting the company's focus on risk management and stability. Additionally, strong sector preferences such as aerospace and defense indicate discernment in aligning with industries resilient to economic pressures.
The investment portfolio's yield saw a modest uptick, with average yield figures tickling upwards to 12.9% and 13.1% at amortized cost and fair value respectively, driven predominantly by surging reference rates on loans. While these figures exude positivity, the company's executives exercise prudent vigilance, recognizing the volatile nature of the current high interest rate environment and the potential for impending economic slowdowns.
Good day, and welcome to the Bain Capital Specialty Finance Third Quarter Ended September 30, 2023 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Katherine Schneider. Please go ahead.
Thanks, Ciko. Good morning, everyone, and welcome to the Bain Capital Specialty Finance Third Quarter ended September 30, 2023, conference call. Yesterday after market closed, we issued our earnings press release and investor presentation of our quarterly results, a copy of which is available on Bain Capital Specialty Finance's Investor Relations website.
Following our remarks today, we will hold a question-and-answer session for analysts and investors. This call is being webcast, and a replay will be available on our website. This call and the webcast are property of Bain Capital Specialty Finance and any unauthorized broadcast in any form is strictly prohibited.
Any forward-looking statements made today do not guarantee future performance, and actual results may differ materially. These statements are based on current management expectations, which include risks and uncertainties, which are identified in the Risk Factors section of our Form 10-Q that could cause actual results to differ materially from those indicated. Bain Capital Specialty Finance assumes no obligation to update any forward-looking statements at this time unless required to do so by law. Lastly, test performance does not guarantee future results.
So with that, I'd like to turn the call over to our Chief Executive Officer, Michael Ewald.
Thanks, Katherine, and good morning, and thank you, everyone, for joining us today on our earnings call.
I'm joined by Mike Boyle, President and our Chief Financial Officer, Sally Dornaus. I'll start with an overview of our third quarter ended September 30, 2023 results and then provide some thoughts on our performance, the overall market environment and our positioning. Thereafter, Mike and Sally will discuss our investment portfolio and financial results in greater detail.
Yesterday after market close, we delivered strong third quarter results. Q3 net investment income per share was $0.55 driven by the continued benefits of higher interest rates across our portfolio. Our net investment income return represented an annualized yield of 12.6% on book value and covered our dividend by 131%. Q3 earnings per share were $0.52, driven by stable credit quality across our portfolio investments during the quarter. Our net income produced an annualized return on book value of 12.0%.
These results led to another consecutive quarter of growth in our net asset value to $17.54 reflecting a 60-basis-point increase from our $17.44 NAV as of June 30. Subsequent to quarter end, our Board declared a fourth quarter dividend equal to $0.42 per share and payable to record date holders as of December 29, 2023. We believe our regular dividend amount represents an attractive yield for our shareholders at a 9.6% annualized yield on ending book value as of September 30.
Our spillover income per share is approximately $0.79 or 1.9x our quarterly regular dividend. We believe this is a healthy amount of undistributed income and provides for increased dividend and NAV stability. Our management team, alongside our Board continues to evaluate the potential for any additional distributions as we near the end of the year.
Turning to the market environment. New loan volumes in the private credit market saw a modest increase during the third quarter from Q2 levels, but volumes remain low overall. Driving the higher activity levels in this quarter with the return of large unit tranche loans as private credit continues to take share away from broadly syndicated loan markets, particularly during periods where new CLO creation remains challenged as the [ BSL ] market is largely dependent on this.
While we observe these trends taking place in the private credit market, we continue to favor middle market sized companies versus large corporate borrowers as many of the core tenants that we value for our direct lenders. For direct lenders provides greater value within this segment of the market in our view. Particularly, we prefer investing in debt structures that benefit from strong lender controls through loan credit documentation containing financial covenants and having control positions among a small lender group.
Our focus on these structures allows us to drive eventual outcomes at our discretion and minimize the lender consensus risk. Within our invested portfolio, 93% of our debt investments are structured with documentation containing financial covenants. And we have majority control positions in 75% of our debt tranches.
For the new companies in which our Private Credit Group platform invested during the third quarter, we were the lead investor driving terms and structure as we leveraged our in-house industry expertise and partner with high-quality sponsors. The investing environment for middle-market lenders continues to be attractive, as demonstrated by favorable terms and structures that are more lender-friendly.
For example, the weighted average spread on our new portfolio company first lien debt investments was approximately 650 basis points this quarter, which produced a weighted average yield of 12% when factoring in current base rates and amortization of original discounts. And the weighted average net debt-to-EBITDA leverage on these new loans was 4.0x, reflecting conservative capital structures in the current market environment.
Our portfolio companies continue to perform well and have proven to be durable thus far in the light of the higher interest rate environment as demonstrated by stable credit quality trends across our portfolio. Our nonaccrual rates continue to be low, with just 1% of the portfolio at fair value, and we had an overall improvement in our watch list investments within our risk ratings.
Notwithstanding these solid portfolio metrics, our team remains vigilant monitoring our portfolio companies closely, particularly given the expectation for a more sustained higher interest rate environment and any potential for an economic slowdown.
I'll now turn the call over to Mike Boyle, our President, to walk through our investment portfolio in greater detail.
Thanks, Mike. Good morning, everyone. I'll start with our investment activity for the third quarter and then provide an update on our portfolio.
New investment fundings during the third quarter were approximately $110 million across 40 portfolio companies including $52 million in 2 new companies and $57 million in add-ons to existing investments. Sales and repayment activity totaled approximately $103 million, resulting in a net funded portfolio growth of $7 million quarter-over-quarter.
This quarter, we remain focused on investing in first lien senior secured loans with 93% of our new investment fundings within first lien structures, and 7% in equity investments. Our new investment fundings were comprised of a mix between new and existing companies, representing 48% and 52%, respectively.
Across our new portfolio companies this quarter, we leverage Bain Capital's in-house industry knowledge and expertise. Our largest new investment was the first lien senior secured loan to forward slope, a provider of mission-critical software and surveillance solutions to the defense industry. We source this investment from a sponsor who has a value-oriented approach with strong experience in aerospace and defense, and who valued our prior experience working with them in this sector. Aerospace and defense is our largest sector exposure and one that we continue to favor in the current environment, given it does not generally cycle with the macro economy.
Another notable new investment this quarter was the first lien senior secured loan and equity co-investment to help drive, a provider of a comprehensive suite of on-site medical services to patients in skilled nursing facilities. While we have shied away from many of the health care physician practice management roll-ups in recent years, we are now focused on finding attractive spots in the health care sector. Our investment thesis for health drive centered on the solid fundamental industry dynamics, which are underpinned by nondiscretionary services. The company's attractive financial profile, demonstrating higher retention rates and partnering with a well-capitalized health care-focused sponsor.
Turning now to the investment portfolio. At the end of the third quarter, the size of our investment portfolio at fair value was approximately $2.4 billion across a highly diversified set of 143 portfolio companies operating across 30 different industries. Our portfolio primarily consists of investments in first lien senior secured loans, given our focus on downside management and investing in the top of the capital structure.
As of September 30, 64% of the investment portfolio at fair value was invested in first lien debt, 4% in second lien debt, 2% in subordinated debt, 4% in preferred equity, 11% in equity and other interests and 15% across our joint ventures. As we have highlighted to our shareholders in prior earnings calls, the decline in our stated first lien exposure is driven by the growth in our joint ventures. Notably, 94% of the underlying investments held in these investment vehicles consists of first lien loans, resulting in a look through first lien exposure of approximately 82% of the portfolio.
As of September 30, 2023, the weighted average yield on the investment portfolio at amortized cost and fair value were 12.9% and 13.1%, respectively, as compared to 12.8% and 13% as of June 30, 2023. The increase was primarily driven by higher reference rates on our loans. And as a reminder, 94% of our debt investments bear interest at a floating rate.
Moving on to portfolio credit quality trends. They were stable quarter-over-quarter. Within our internal risk rating scale, we saw an improvement within our risk rating 1 and 2 investments. which indicates that a company was performing in line or better than expectations relative to our initial underwriting. As of September 30, these investments comprise 95% of our portfolio at fair value, up from 91% as of the prior quarter end. Risk rating 3 and 4 investments comprised 5% of our portfolio at fair value, down from 8.5% as of Q2.
Investments on nonaccrual are 1.5% and 1.0% of the total investment portfolio at amortized cost and fair value, respectively, as compared to 2.1% and 0% as of June 30. We believe our nonaccrual rates are among the lowest level across the BDC sector. Credit fundamentals remain solid in our portfolio with a median leverage of 5.0x as of September 30. as compared to 5.1x as of June 30.
Sally will now provide a more detailed financial review.
Thank you, Mike, and good morning, everyone. I'll start the review of our third quarter 2023 results with our income statement. Total investment income was $72.4 million for the 3 months ended September 30, 2023, as compared to $75.7 million for the 3 months ended June 30, 2023. The decrease in investment income was primarily driven by a decrease in interest income as a result of lower interest income and other income.
BCSF continues to benefit from high-quality sources of investment income, largely driven by contractual cash income across its investments. Interest income and dividend income represent 99% of our total investment income in Q3 with no prepayment related income this quarter. Other income comprised only 1% of our total investment income. Total expenses for the third quarter were $36.1 million as compared to $35.7 million in the second quarter.
Net investment income for the quarter was $35.6 million or $0.55 per share as compared to $38.9 million or $0.60 per share for the prior quarter. During the 3 months ended September 30, 2023, the company had net realized and unrealized losses of $1.8 million. Net income for the 3 months ended September 30, 2023, was $33.9 million or $0.52 per share.
Moving over to our balance sheet. As of September 30, our investment portfolio at fair value totaled $2.4 billion and total assets of $2.6 billion. Total net assets were $1.1 billion as of September 30. NAV per share was $17.54, up from $17.44 at the end of the second quarter, representing a 0.6% increase quarter-over-quarter. The increase in our NAV was driven by the over earnings of our dividend coupled with the relative stability in the value of our investments during the quarter.
At the end of Q3, our debt-to-equity ratio was 1.22x as compared to 1.33x from the end of Q2. Our net leverage ratio, which represents principal debt outstanding less cash and unsettled trades was 1.12x at the end of Q3 as compared to 1.13x at the end of Q2. We remain comfortable operating in the middle of our net target leverage ratio of between 1 and 1.25x.
As of September 30, approximately 56% of our outstanding debt was in floating rate debt, and 44% in fixed rate debt. The company does not have any debt maturities until 2026, and the weighted average maturity across our total debt commitments was 4.5 years at September 30.
Our debt funding continues to benefit from low fixed rate debt structures as we access the unsecured markets during a period of low interest rates. The weighted average interest rate on our unsecured notes is 2.75%. For the 3 months ended September 30, 23, the weighted average interest rate on our debt outstanding was 5.4% as compared to 5.2% as of the prior quarter end. The increase was driven by higher SOFR rates on our floating rate debt structures.
Liquidity at quarter end totaled $329 million, including $224 million of undrawn capacity on our revolving credit facility, $105 million of cash and cash equivalents, including $26 million of restricted cash and less than $1 million of unsettled trades net of receivables and payables of investments.
With that, I will turn the call back over to Mike for closing remarks.
Thanks, Sally. In closing, we're pleased to deliver another quarter of strong earnings for our shareholders, demonstrated by high levels of net investment income that are well in excess of our dividend and modest NAV growth as our underlying borrowers continue to perform well.
Bain Capital Credit remains well positioned to execute on its direct lending strategy, given our platform's expertise, resources and relationships that have been built on 25 years of experience investing in the core middle market. We remain committed to delivering value for our shareholders, and thank you for the privilege of managing our shareholders' capital.
Ciko, please open the line for questions.
[Operator Instructions] Thank you. The first question comes from Arren Cyganovich with Citi.
You talk a little bit about the investing environment. You mentioned attractive characteristics today. You're seeing wider spreads and lower leverage? Are you seeing any kind of pickup in activity from sponsors? And what is your pipeline like these days for new investments?
Yes, Arren. Look, I think it kind of varies a little bit, maybe not week to week or maybe month to month. We do continue to have busy months, not so busy months. Sponsors are definitely showing us things that there might be a little bit of going through the motions and just trying to see whether they can maybe pick up some value plays, but we're not necessarily seeing a wholesale change from the current, I'd say, stable level. That's a little bit depressed from kind of pre-COVID and certainly 2021. But it's qualified as fine, not great from a deal flow perspective.
Okay. And how does it look from an international perspective versus the U.S.
It's still pretty balanced right now. I definitely say last year, we were in 2022. We were more U.S. heavy, more Europe heavy in 2021. And I'd say this year, we're probably a little bit more balanced with Australia and New Zealand being a smaller piece and that just kind of being steady. So I don't think there's any notable differences between the two markets right now.
Our next question comes from Paul Johnson with KBW.
I was just wondering if you can kind of comment on, I guess, the EBITDA growth trends that you're seeing in your portfolio, I guess, both domestically as well as internationally. I know it's kind of hard to generalize maybe all of international, but just in general, kind of Europe versus U.S., what's been the performance like in the portfolio?
Sure. So performance has been quite strong across both markets, referring to U.S. and Europe broadly. I do think top lines have held in, particularly in the industries we've selected to invest in. And so as we noted, 95% of our portfolio is in line with our original underwriting. And most of those original underwrites include some sort of EBITDA growth in the 15% to 20% sort of CAGRs on the EBITDA line. So we've seen much of the portfolio perform in line with that sort of 15% to 20% year-over-year EBITDA growth. But that's largely driven by, again, the sectors we've chosen to invest in, and we've really been able to shy away for many more cyclical sectors that might not disturb -- or show the same amount of growth in this type of market environment.
And just kind of generally, I guess, what are your thoughts on where the portfolio or where the BDC is today from a leverage standpoint, I believe we're around 1.2x kind of gross levels as of the third quarter within, obviously, the target range that you guys run with. But just kind of given the uncertainty running into next year, potentially the higher for longer scenario. Do you guys have any thoughts around where you'd like leverage to be in the BDC.
Sure. So I do look at the net level, more specifically when I think about where we're running our leverage versus that 1.12x, which is really right in that center of the range. I do think given the market environment, the fact that interest rates are likely to be higher for longer, operating at the lower end of our leverage range while we wait for new deal activity to pick up. And as Ewald commented earlier, the pipeline to get a little bit better than good and go back to great. I think we think about bringing the leverage back up. But in the near term, I do think we'd probably trend towards the lower end of our range so that we have dry powder to take advantage of future market opportunity.
That's helpful. And last one for me. Was there anything specific driving, I guess, the credit, the internal credit rating sort of increase during the quarter, there's a big jump in the rated 2 category from 91% to 95%. Was that due to any sort of markups or markdowns or any sort of activity in the portfolio that drove that?
It is really driven by two companies that we had previously had on our watch list. They were companies that had been impacted by COVID and were really recovering. It took a few years to recover back to pre-COVID earnings levels. And so it was really two companies that performed better that we're taking off the watch list that drove that change.
The next question is from Derek Hewett with Bank of America.
Could you talk a little bit about the mechanics of the incentive fee since it declined on a quarter-over-quarter basis? And should we expect it to normalize like prospectively?
Yes. Thanks for the question. I think we talked about that on the last couple of quarters' calls because of the lower levels of incentive fee versus prior. We had our COVID quarter that dropped off and the mechanics of the fee caused this kind of lower incentive level but should go back to normal in the next 1 or 2 quarters. So I would expect run rate to be a bit higher than that.
Okay. And then in regards to the dividends, you're significantly over earning it. If you adjust for the lower incentive fee, you're still materially over-earning the dividend. What are your thoughts on an additional increase in the core dividend versus -- or potentially implementing kind of a supplemental formulaic type of special dividend.
Yes. That's something that we talk about often. And we've talked about with our management team and our Board, obviously, the spillover gives us some good NAV stability, but we do have this ability to either do a possibly an additional dividend or increase the dividend. Both of those things are being considered.
[Operator Instructions] This concludes our question-and-answer session. I would like to turn the conference back over to Mike Ewald for closing remarks.
Great. Thanks, Ciko. I just wanted to thank everyone again for your time today, and we certainly appreciate your continued support and look forward to bringing you more news around executing our middle market investing strategy through BCSF in the future. I hope everyone has a good day. Thanks again.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.